Latest news with #June2025
Yahoo
5 hours ago
- Business
- Yahoo
Kinross Gold (KGC) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Kinross Gold (KGC) reported revenue of $1.73 billion, up 41.7% over the same period last year. EPS came in at $0.44, compared to $0.14 in the year-ago quarter. The reported revenue represents a surprise of +28.3% over the Zacks Consensus Estimate of $1.35 billion. With the consensus EPS estimate being $0.33, the EPS surprise was +33.33%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Kinross Gold performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Gold equivalent ounces - Produced - Operations Total: 530.08 Moz compared to the 480.41 Moz average estimate based on three analysts. Attributable all-in sustaining cost per equivalent ounce sold: $1.49 billion versus $1.57 billion estimated by two analysts on average. Average realized gold price per ounce: $3,284.00 versus $2,885.45 estimated by two analysts on average. Production cost of sales per equivalent ounce sold: $1080 per ounce versus $1198.6 per ounce estimated by two analysts on average. View all Key Company Metrics for Kinross Gold here>>> Shares of Kinross Gold have returned +3.1% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kinross Gold Corporation (KGC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Times of Oman
3 days ago
- Business
- Times of Oman
Oman's total refinery production rises by 1.6%
Muscat: Oman's total refinery production saw a growth of 1.6 percent by the end of June 2025. However, MOGAS (motor gasoline) production in June 2025 saw a decrease of 17.1 percent compared to the previous month. Preliminary statistics from the National Centre for Statistics and Information (NCSI) indicate that the production of Regular MOGAS (91) increased by 11.5 percent, reaching 8.6595 million barrels by the end of June 2025, compared to 7.7679 million barrels during the same period in 2024. Sales also rose by 2 percent to 6.9645 million barrels, compared to 6.8287 million barrels by the end of June 2024. Exports of Regular MOGAS increased by 6.1 percent to 1.4946 million barrels, up from 1.4084 million barrels by the end of June 2024. In contrast, production of MOGAS (95) saw a 2.2 percent decrease, reaching 6.4184 million barrels compared to 6.5595 million barrels during the same period in 2024. However, its sales increased slightly by 0.9 percent to 6.4696 million barrels, up from 6.4124 million barrels by the end of June 2024. Exports of MOGAS-95 achieved a 20.6 percent growth, reaching 690,700 barrels compared to 572,800 barrels in the same period last year. The production of Gas Oil (Diesel) recorded a 3.8 percent increase, reaching 16.6214 million barrels, compared to 16.0166 million barrels by the end of June 2024. Sales also rose by 5.8 percent to 7.2137 million barrels, compared to 6.8202 million barrels in the same period last year. However, its exports decreased by 5.5 percent, registering 8.5506 million barrels compared to 9.0521 million barrels by the end of June 2024. Jet fuel production experienced a 13.1 percent decrease, registering 4.9458 million barrels compared to 5.6923 million barrels for the same period in 2024. Its sales also declined by 6.4 percent to 1.8676 million barrels, compared to 1.9953 million barrels last year. Exports decreased by 16.3 percent, reaching 3.019 million barrels compared to 3.605 million barrels by the end of June 2024. As for Liquefied Petroleum Gas (LPG) production, it saw a slight increase of 0.2 percent, reaching 3.7645 million barrels, compared to 3.7556 million barrels during the same period in 2024. Its sales rose by 22.2 percent to 1.9444 million barrels, against 1.5912 million barrels for the same period in 2024, while its exports decreased by 60.3 percent, reaching 111,500 barrels compared to 280,700 barrels by the end of June 2024. Regarding petrochemicals, statistics showed that Benzene production increased by 3.1 percent, registering 86,000 metric tonnes, compared to 83,500 metric tonnes for the same period in 2024. Paraxylene production achieved a 6.8 percent growth, registering 283,000 metric tonnes by the end of June 2025, against 265,100 metric tonnes by the end of June 2024. Polypropylene recorded the highest production growth rate at 73.4 percent, reaching 176,600 metric tonnes compared to 101,800 metric tonnes during the same period last year. Despite this, its sales decreased by 9.2 percent, registering 15,400 metric tonnes compared to 17,000 metric tonnes in the same period last year. In terms of exports, Benzene exports increased by 0.4 percent by the end of June 2025, registering 81,900 metric tonnes compared to 81,500 metric tonnes by the end of June 2024. Paraxylene exports recorded significant growth of 22.8 percent, reaching 312,700 metric tonnes compared to 254,700 metric tonnes in the same period last year. Polypropylene exports also showed remarkable growth of 61.6 percent, reaching 131,200 metric tonnes compared to 81,200 metric tonnes in the same period of 2024.
Yahoo
5 days ago
- Business
- Yahoo
AI referrals to top websites were up 357% year-over-year in June, reaching 1.13B
AI referrals to websites still have a way to go to catch up to the traffic that Google Search provides, but they're growing quickly. According to new data from market intelligence provider Similarweb, AI platforms in June generated over 1.13 billion referrals to the top 1,000 websites globally, a figure that's up 357% since June 2024. However, Google Search still accounts for the majority of traffic to these sites, accounting for 191 billion referrals during the same period of June 2025. One particular category of interest these days is news and media. Online publishers are seeing traffic declines and are preparing for a day they're calling 'Google Zero,' when Google stops sending traffic to websites. For instance, The Wall Street Journal recently reported on data that showed how AI overviews were killing traffic to news sites. Plus, a Pew Research Center study out this week found that in a survey of 900 U.S. Google users, 18% of some 69,000 searches showed AI Overviews, which led to users clicking links 8% of the time. When there was no AI summary, users clicked links nearly twice as much, or 15% of the time. Similarweb found that June's AI referrals to news and media websites were up 770% since June 2024. Some sites will naturally rank higher than others that are blocking access to AI platforms, as The New York Times does, as a result of its lawsuit with OpenAI over the use of its articles to train its models. In the news media category, Yahoo led with 2.3 million AI referrals in June 2025, followed by Yahoo Japan (1.9M), Reuters (1.8M), The Guardian (1.7M), India Times (1.2M), and Business Insider (1.0M). In terms of methodology, Similarweb counts AI referrals as web referrals to a domain from an AI platform like ChatGPT, Gemini, DeepSeek, Grok, Perplexity, Claude, and Liner. ChatGPT dominates here, accounting for more than 80% of the AI referrals to the top 1,000 domains. The company's analysis also looked at other categories beyond news, like e-commerce, science and education, tech/search/social media, arts and entertainment, business, and others. In e-commerce, Amazon was followed by Etsy and eBay when it came to those sites seeing the most referrals, at 4.5M, 2.0M, and 1.8M, respectively, during June. Among the top tech and social sites, Google, not surprisingly, was at the top of the list, with 53.1 million referrals in June, followed by Reddit (11.1M), Facebook (11.0M), Github (7.4M), Microsoft (5.1M), Canva (5.0M), Instagram (4.7M), LinkedIn (4.4M), Bing (3.1M), and Pinterest (2.5M). The analysis excluded the OpenAI website because so many of its referrals were from ChatGPT, pointing to its services. Across all other domains, the No. 1 site by AI referrals for each category included YouTube (31.2M), Research Gate (3.6M), Zillow (776.2K), (992.9K), Wikipedia (10.8M), (5.2M), (1.2M), Home Depot (1.2M), Kayak (456.5K), and Zara (325.6K). Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
TechCrunch
6 days ago
- Business
- TechCrunch
AI referrals to top websites were up 357% year-over-year in June, reaching 1.13B
AI referrals to websites still have a way to go to catch up to the traffic that Google Search provides, but they're growing quickly. According to new data from market intelligence provider Similarweb, AI platforms in June generated over 1.13 billion referrals to the top 1,000 websites globally, a figure that's up 357% since June 2024. However, Google Search still accounts for the majority of traffic to these sites, accounting for 191 billion referrals during the same period of June 2025. One particular category of interest these days is news and media. Online publishers are seeing traffic declines and are preparing for a day they're calling 'Google Zero,' when Google stops sending traffic to websites. For instance, The Wall Street Journal recently reported on data that showed how AI overviews were killing traffic to news sites. Plus, a Pew Research Center study out this week found that in a survey of 900 U.S. Google users, 18% of some 69,000 searches showed AI Overviews, which led to users clicking links 8% of the time. When there was no AI summary, users clicked links nearly twice as much, or 15% of the time. Similarweb found that June's AI referrals to news and media websites were up 770% since June 2024. Some sites will naturally rank higher than others that are blocking access to AI platforms, as The New York Times does, as a result of its lawsuit with OpenAI over the use of its articles to train its models. In the news media category, Yahoo led with 2.3 million AI referrals in June 2025, followed by Yahoo Japan (1.9M), Reuters (1.8M), The Guardian (1.7M), India Times (1.2M), and Business Insider (1.0M). In terms of methodology, Similarweb counts AI referrals as web referrals to a domain from an AI platform like ChatGPT, Gemini, DeepSeek, Grok, Perplexity, Claude, and Liner. ChatGPT dominates here, accounting for more than 80% of the AI referrals to the top 1,000 domains. The company's analysis also looked at other categories beyond news, like e-commerce, science and education, tech/search/social media, arts and entertainment, business, and others. Screenshot In e-commerce, Amazon was followed by Etsy and eBay when it came to those sites seeing the most referrals, at 4.5M, 2.0M, and 1.8M, respectively, during June. Among the top tech and social sites, Google, not surprisingly, was at the top of the list, with 53.1 million referrals in June, followed by Reddit (11.1M), Facebook (11.0M), Github (7.4M), Microsoft (5.1M), Canva (5.0M), Instagram (4.7M), LinkedIn (4.4M), Bing (3.1M), and Pinterest (2.5M). The analysis excluded the OpenAI website because so many of its referrals were from ChatGPT, pointing to its services. Across all other domains, the No. 1 site by AI referrals for each category included YouTube (31.2M), Research Gate (3.6M), Zillow (776.2K), (992.9K), Wikipedia (10.8M), (5.2M), (1.2M), Home Depot (1.2M), Kayak (456.5K), and Zara (325.6K).
Medscape
23-07-2025
- Health
- Medscape
Experts Outline Safety Guidelines for Fully Ablative Lasers
Despite the growing use of fully ablative laser resurfacing for photodamaged skin, standard protocols for managing adverse events remain limited. A newly published international consensus statement now aims to close that gap. Published in the June 2025 issue of Lasers in Surgery and Medicine , the consensus statement brings together expert recommendations on how to prevent and manage complications related to fully ablative laser resurfacing of the face. The authors emphasize that, while individual practice styles vary, consistent themes emerged — highlighting the importance of patient selection, comprehensive counseling, and detailed pre- and postprocedural care to improve safety and outcomes. Why This Matters Fully ablative carbon dioxide and erbium-doped yttrium aluminum garnet lasers remain gold standards for treating photodamaged skin because of their ability to provide deep resurfacing and robust collagen remodeling. But these benefits come at a cost: More extensive skin injury and a higher risk for complications compared with fractional or nonablative lasers, according to the authors. Arisa Ortiz, MD Risks include prolonged erythema, infection, pigmentary alterations, and scarring — issues that can be distressing to patients and difficult to manage without a standardized care framework. The consensus authors emphasized that, until now, clinical protocols for the prevention and management of complications have been largely based on anecdotal and variable experience. Asked to comment on the consensus statement, one of the consensus authors, Arisa Ortiz, MD, dermatologist and director of Laser and Cosmetic Dermatology at UC San Diego Health, San Diego, called the statement 'a landmark in laser dermatology.' 'This consensus is a landmark in laser dermatology, finally providing unified, expert-backed guidance for a procedure that has historically lacked standardization. It gives clinicians a clear, practical roadmap for safe and effective fully ablative resurfacing,' Ortiz said. Pooja Sodha, MD Pooja Sodha, MD, associate professor of dermatology at George Washington School of Medicine & Health Sciences and director of the Center for Laser and Cosmetic Dermatology, both in Washington, DC, agreed with this sentiment, emphasizing the document is especially useful in clinical practice. 'This consensus helps to organize the thought process of how to prepare, counsel, and treat patients, almost providing a step-by-step guide of items to consider. This is great for new and old practitioners,' Sodha told Medscape Medical News . She was not an author of the statement. Key Recommendations The consensus outlines detailed step-by-step strategies to help clinicians reduce the risk for complications following fully ablative laser resurfacing. These recommendations span the entire patient journey — from pretreatment counseling to postoperative monitoring and management of adverse effects: Infection prevention. The authors recommend antiviral prophylaxis for all patients undergoing full-face resurfacing, even when treatment is limited to perioral or periocular areas. 'The preferred agent for antiviral prophylaxis is valacyclovir, unless otherwise indicated,' they wrote. The consensus group also noted that oral or topical antibacterial prophylaxis may be appropriate in higher-risk individuals, such as those with diabetes or a history of methicillin-resistant Staphylococcus aureus colonization. The authors recommend antiviral prophylaxis for all patients undergoing full-face resurfacing, even when treatment is limited to perioral or periocular areas. 'The preferred agent for antiviral prophylaxis is valacyclovir, unless otherwise indicated,' they wrote. The consensus group also noted that oral or topical antibacterial prophylaxis may be appropriate in higher-risk individuals, such as those with diabetes or a history of methicillin-resistant colonization. Postprocedural wound care. The authors emphasized the importance of frequent cleansing with soaks and keeping the skin moist with emollients. 'It is beneficial to apply topical lanolin‐free ointment or other appropriate posttreatment topical product,' the group noted. The authors emphasized the importance of frequent cleansing with soaks and keeping the skin moist with emollients. 'It is beneficial to apply topical lanolin‐free ointment or other appropriate posttreatment topical product,' the group noted. Early recognition of infection. Patients should be educated to report signs such as increasing pain, drainage, erythema, or fever. 'It is appropriate to promptly evaluate (in person or virtually) patients with signs or symptoms concerning for infection,' the authors wrote. Patients should be educated to report signs such as increasing pain, drainage, erythema, or fever. 'It is appropriate to promptly evaluate (in person or virtually) patients with signs or symptoms concerning for infection,' the authors wrote. Addressing pigmentary changes. The authors note that pigmentary changes such as hyperpigmentation, a common postprocedural complication, often resolve over 6-12 months, but proactive management may improve outcomes. The panel supports the use of 'topical lightening or bleaching agents' as helpful for treating hyperpigmentation and considers laser-based interventions or oral tranexamic acid in select patients, provided clotting risks are ruled out. The authors note that pigmentary changes such as hyperpigmentation, a common postprocedural complication, often resolve over 6-12 months, but proactive management may improve outcomes. The panel supports the use of 'topical lightening or bleaching agents' as helpful for treating hyperpigmentation and considers laser-based interventions or oral tranexamic acid in select patients, provided clotting risks are ruled out. Scarring management. The consensus group recommended addressing scarring at the earliest signs. Interventions include intralesional corticosteroids or 5-fluorouracil, vascular lasers, or 'laser-assisted drug delivery of corticosteroid and/or 5‐fluorouracil,' according to the authors. Challenges and Controversies While the consensus process produced strong agreement in many areas, some topics remained divisive. Only a subset of proposed adverse events and contraindications reached full consensus. For instance, pretreatment counseling about eruptive keratoacanthomas or milia as possible adverse events did not meet agreement thresholds, according to the authors. Ortiz noted that disagreement over rare complications reflects the complexity of real-world care. 'While most statements achieved strong agreement, there were important areas — like counseling for rare complications or defining contraindications — where expert opinions diverged,' she explained. 'These gray zones underscore the need for continued discussion and individualized care.' The risk for vitiligo induction after laser resurfacing is still under debate. While not a formal contraindication, the authors suggest that 'practitioners might consider incorporating family history assessments into pretreatment consultations.' The panel also noted that while darker Fitzpatrick skin types are not a contraindication to fully ablative laser resurfacing of the face, these patients face higher risks for postinflammatory pigmentary changes. Providers should employ strategies to reduce risk, which include conservative settings, rigorous sun protection, and topical corticosteroids after treatment when appropriate, according to the consensus group. Sodha emphasized this point as an important area for ongoing refinement: 'I believe this statement is important — 'Darker Fitzpatrick skin types were not considered a contraindication to treatment' — and it highlights that our settings in this population need to be adjusted and these patients need to be counseled on the pigmentary risks, but treatment is still possible,' she explained. 'Building continued comfort here and defining the right parameters is worthy of a little more consideration in future guideline development.' Sodha also noted that although the recommendations may seem straightforward, successful integration takes practice. 'The steps themselves are not difficult. This is about common sense,' she said. 'These recommendations remind us how important repetition is in integrating these principles so they are second nature.' Looking Ahead This expert-driven consensus offers a foundation for safe and consistent care in laser resurfacing but also highlights areas for future research, according to the authors. Ortiz told Medscape Medical News that future data will be essential to address gaps in evidence. 'There's a pressing need for high-quality studies focused on managing complications like hypopigmentation and scarring, particularly to better understand long-term pigmentary outcomes and optimize treatment safety across diverse populations.' The study received no specific funding. Several authors disclosed financial relationships with industry, while Ortiz and Podha reported no relevant disclosures.
